Skip to content

A multicenter prospective open natural selection real-world study of the efficacy and safety of MaiLuoShuTong Pill for the prevention of deep vein thrombosis in ICU patients

A multicenter prospective open natural selection real-world study of the efficacy and safety of MaiLuoShuTong Pill for the prevention of deep vein thrombosis in ICU patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2024000424
Enrollment
Unknown
Registered
2024-09-11
Start date
2024-09-15
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Deep venous thrombosis

Interventions

Use of Mailuoshutong pill for prevention of deep vein thrombosis in ICU patients:Use of Mailuoshutong pill

Sponsors

Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: (1) ICU patients =18 years old and =90 years old regardless of gender; (2) The informed consent has been signed by himself or his family members.

Exclusion criteria

Exclusion criteria: (1) Patients expected to stay in ICU for less than 48 hours; (2) Patients with DVT before admission to ICU; (3) Patients with allergic constitution; (4) Patients with obvious liver disease active bleeding or bleeding tendency; (5) Patients considered by the investigators to be unsuitable for participation in this study such as pregnant women and patients with certain medical conditions that prevent bilateral Doppler examination (such as lower limb amputation).

Design outcomes

Primary

MeasureTime frame
Incidence of new DVT during ICU hospitalization;

Secondary

MeasureTime frame
D-dimer, coagulation function index, platelet count;

Countries

China

Contacts

Public ContactKailiang Fan

Affiliated Hospital of Shandong University of Traditional Chinese Medicine

18560769418@163.com15098966658

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026